Torrent Pharma shares hit 52-week high; here's why
The USFDA conducted the pre-approval inspection at the company’s oral-oncology manufacturing facility situated in Bileshwarpura, Gujarat from December 5 to December 11 last year.
united states food and drug administration usfda
March 2024
November 2023
Aurobindo Pharma swings to 52-week high; here's why
The scrip opened higher at ₹1,014.95, up 0.73%, as against the previous closing price of ₹1,007.50
